CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Jamjoom Pharmaceuticals Fctry Cmpny SJSC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Jamjoom Pharmaceuticals Fctry Cmpny SJSC
Al-Hamra Dist, Corniche Road
Phone: +966 126081111p:+966 126081111 JEDDAH, 21442  Saudi Arabia Ticker: 40154015
Business Summary
Jamjoom Pharmaceuticals Factory Company SJSC is a Saudi Arabia-based Company, which produces human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhea, vomiting, ulcer and acidity, treatment of various skin infections, cancer diseases, eye drops and ointments and cosmeceuticals. The Company operates two segments, which include pharmaceutical products, that represents medicines or drugs, which all are essential for the prevention and treatment of diseases, and protection of public health; and Consumer health products segment that represents the products sold directly to consumers. The Company’s subsidiaries include Al Jamjoom Pharma for Pharmaceutical Industries and Jamjoom Pharmaceutical Industry and Commerce Company Limited and the Company also operates approximately 8 branches.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman of the Board Mahmoud Y.Salah Jamjoom 63 6/19/2022 6/19/2022
Chief Executive Officer Tarek Y.Hosni 59 2/15/2021 2/15/2021
Non-Executive Vice Chairman of the Board Ahmad Y.Salah Jamjoom 38 6/19/2022
12 additional Officers and Directors records available in full report.

General Information
Number of Employees: 1,027 (As of 12/31/2023)
Outstanding Shares: 70,000,000 (As of 12/31/2023)
Stock Exchange: SAU
Fax Number: +966 126081222


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, April 28, 2024